Literature DB >> 10086931

Evidence for using nebulised antibiotics in cystic fibrosis.

S P Conway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10086931      PMCID： PMC1717877          DOI： 10.1136/adc.80.4.307

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  25 in total

1.  Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  M E Hodson; A R Penketh; J C Batten
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

2.  Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa.

Authors:  R J Stead; M E Hodson; J C Batten
Journal:  Br J Dis Chest       Date:  1987-07

3.  Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis.

Authors:  J M Littlewood; M G Miller; A T Ghoneim; C H Ramsden
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

4.  Nebulized gentamicin in children and adolescents with cystic fibrosis.

Authors:  P Kun; L I Landau; P D Phelan
Journal:  Aust Paediatr J       Date:  1984-03

5.  Quantitative deposition of aerosolized gentamicin in cystic fibrosis.

Authors:  J S Ilowite; J D Gorvoy; G C Smaldone
Journal:  Am Rev Respir Dis       Date:  1987-12

6.  Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.

Authors:  T Jensen; S S Pedersen; S Garne; C Heilmann; N Høiby; C Koch
Journal:  J Antimicrob Chemother       Date:  1987-06       Impact factor: 5.790

7.  Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.

Authors:  U B Schaad; J Wedgwood-Krucko; S Suter; R Kraemer
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

8.  Long-term tobramycin aerosol therapy in cystic fibrosis.

Authors:  G Steinkamp; B Tümmler; M Gappa; A Albus; J Potel; G Döring; H von der Hardt
Journal:  Pediatr Pulmonol       Date:  1989

9.  Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis.

Authors:  D Stephens; N Garey; A Isles; H Levison; R Gold
Journal:  Pediatr Infect Dis       Date:  1983 May-Jun

10.  Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.

Authors:  P M Mendelman; A L Smith; J Levy; A Weber; B Ramsey; R L Davis
Journal:  Am Rev Respir Dis       Date:  1985-10
View more
  6 in total

Review 1.  Bordetella bronchiseptica pneumonia: beware of the dog!

Authors:  Jamie Clements; Christopher McGrath; Charlie McAllister
Journal:  BMJ Case Rep       Date:  2018-04-27

Review 2.  Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature.

Authors:  Federico Marchetti; Luisella Giglio; Manila Candusso; Dino Faraguna; Baroukh M Assael
Journal:  Eur J Clin Pharmacol       Date:  2004-03-05       Impact factor: 2.953

Review 3.  Nebulized antibiotics in cystic fibrosis.

Authors:  Isabelle Sermet-Gaudelus; Yann Le Cocguic; Agnés Ferroni; Marlène Clairicia; Joel Barthe; Jan-Pierre Delaunay; Valentine Brousse; Gérard Lenoir
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center.

Authors:  Danish Abdul Aziz; Aiza Abbas; Anusha Alam; Namrah Aziz
Journal:  Lung India       Date:  2022 May-Jun

5.  Individualized supervised resistance training during nebulization in adults with cystic fibrosis.

Authors:  Ina Shaw; Janine E Kinsey; Roxanne Richards; Brandon S Shaw
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

6.  Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection.

Authors:  Nina Mann; Shirley Murray; Zhe Hui Hoo; Rachael Curley; Martin J Wildman
Journal:  F1000Res       Date:  2017-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.